Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
495.91
+4.34 (+0.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
966,166
Open
497.00
Bid (Size)
494.96 (1)
Ask (Size)
514.55 (1)
Prev. Close
491.57
Today's Range
491.52 - 498.77
52wk Range
340.20 - 498.77
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Gene Editing Stocks Shaping the Future of Medicine
Today 16:45 EDT
Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions
Via
InvestorPlace
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street
July 21, 2024
Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years!
Via
The Motley Fool
Performance
YTD
+20.69%
+20.69%
1 Month
+5.80%
+5.80%
3 Month
+24.00%
+24.00%
6 Month
+12.68%
+12.68%
1 Year
+38.89%
+38.89%
More News
Read More
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
Via
The Motley Fool
The 3 Best Neuroscience Biotech Stocks to Buy Now
July 19, 2024
Via
InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:VRTX.
July 19, 2024
Via
Chartmill
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
July 11, 2024
Via
Benzinga
Check Out What Whales Are Doing With VRTX
July 10, 2024
Via
Benzinga
Why the quality investor may take a look at NASDAQ:VRTX.
July 03, 2024
Via
Chartmill
3 Gene Editing Stocks That Could Grow Your Wealth
July 17, 2024
Via
InvestorPlace
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
July 16, 2024
Via
The Motley Fool
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
July 15, 2024
Via
The Motley Fool
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Via
The Motley Fool
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
July 14, 2024
Via
The Motley Fool
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
July 09, 2024
Via
InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
July 08, 2024
Via
Talk Markets
3 No-Brainer Stocks to Buy in July
July 08, 2024
Via
The Motley Fool
3 Pharma Stocks Already Ushering in the Next Biotech Boom
July 08, 2024
Via
InvestorPlace
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).
July 06, 2024
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in July 2024
July 05, 2024
Via
InvestorPlace
1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever
July 05, 2024
Via
The Motley Fool
Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
July 05, 2024
Via
The Motley Fool
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Via
The Motley Fool
3 Top-Rated Gene Editing Stocks Actually Making Money
July 03, 2024
Via
InvestorPlace
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
July 02, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.